Niederer Kraft Frey has advised GENFIT, a late-stage biopharmaceutical company, on the acquisition of Versantis. GENFIT is a pioneer in liver disease research and development, publicly traded company listed on the Nasdaq Global Select Market
Tags :Shu Bernet-Zhang
Niederer Kraft Frey advised the Beijing company Lepu Medical Technology on its successful USD 224 million offering and listing of global depositary receipts on SIX Swiss Exchange within the framework of the China-Switzerland Stock Connect
Baker McKenzie has acted as legal advisor on the successful offering and listings of Global Depositary Receipts (GDR) on SIX Swiss Exchange of four Chinese companies: GEM Co., Gotion High-tech Co., Keda Industrial Group Co.,
Global Blue Group Holding has completed an investment agreement with CK Opportunities Wolverine, an investment fund co-managed by Certares Opportunities, a global travel, tourism and hospitality investment firm, and Knighthead Opportunities Capital Management, a leading
Partners Group, a global private markets firm, has, on behalf of its clients, agreed to acquire a significant minority stake in Swiss watchmaker Breitling from CVC Capital Partners Fund VI and management. Closing of the
Idorsia launches at-market rights offering targeting gross proceeds of approximately CHF 575m
Idorsia, a Swiss biopharmaceutical company, completed a private placement with institutional investors of 11m new registered shares, corresponding to 8.4% of its currently issued share capital, issued out of its authorized share capital by way of
